Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76,466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Follicular dendritic cell sarcoma of the pharyngeal region.
Hu T, Wang X, Yu C, Yan J, Zhang X, Li L, Li X, Zhang L, Wu J, Ma W, Li W, Wang G, Zhao W, Gao X, Zhang D, Zhang M. Hu T, et al. Among authors: wu j. Oncol Lett. 2013 May;5(5):1467-1476. doi: 10.3892/ol.2013.1224. Epub 2013 Mar 4. Oncol Lett. 2013. PMID: 23761812 Free PMC article.
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.
Li X, Cheng Y, Zhang M, Yan J, Li L, Fu X, Zhang X, Chang Y, Sun Z, Yu H, Zhang L, Wang X, Wu J, Li Z, Nan F, Tian L, Li W, Young KH. Li X, et al. Among authors: wu j. J Hematol Oncol. 2018 Jan 31;11(1):15. doi: 10.1186/s13045-018-0559-7. J Hematol Oncol. 2018. PMID: 29386072 Free PMC article.
Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients.
Sun Y, Li L, Li X, Zhang L, Wang X, Fu X, Sun Z, Zhang X, Li Z, Wu J, Yu H, Chang Y, Yan J, Wu X, Zhou Z, Nan F, Tian L, Zhang M. Sun Y, et al. Among authors: wu x, wu j. Ther Adv Med Oncol. 2020 May 27;12:1758835920923829. doi: 10.1177/1758835920923829. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32550864 Free PMC article.
Effective Treatment with PD-1 Antibody, Chidamide, Etoposide, and Thalidomide (PCET) for Relapsed/Refractory Natural Killer/T-Cell Lymphoma: A Report of Three Cases.
Du L, Zhang L, Li L, Li X, Yan J, Wang X, Fu X, Sun Z, Zhang X, Li Z, Wu J, Yu H, Chang Y, Zhou Z, Nan F, Wu X, Tian L, Zhang M. Du L, et al. Among authors: wu x, wu j. Onco Targets Ther. 2020 Jul 27;13:7189-7197. doi: 10.2147/OTT.S262039. eCollection 2020. Onco Targets Ther. 2020. PMID: 32801749 Free PMC article.
76,466 results
You have reached the last available page of results. Please see the User Guide for more information.